Therefore, not only is SF3B1 overexpressed in PDAC, which may influence the splicing profiles in cancer cells, but the splicing inhibitor Pladienolide-B reduces pivotal functional (proliferation, migration) and stem-associated features (colony- and sphere-formation), likely by altering key signaling and splicing events. Here, SF3B1 is linked to cancer.